|
Form 4 Filings | Insider Buys | Significant Buys |
Penny Stocks Insider Buying |
Insider Sales |
| Insider Buy Sell Ratios | Stock Options |
Insider Trading Stock Screener |
Insider Trading Graph View |
Insider Watch |
Sec Filings Insider Trading - Gemphire Therapeutics Inc. (GEMP)
|
|
"Insiders might sell their shares for any number of reasons, but they buy them for only one:
they think the price will rise" - Peter Lynch ==>> What is insider trading>> |
Common stock purchase or sale:
| Transaction Date |
Reported Date |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2018-02-08 Purchase |
2018-02-12 4:40 pm |
Gemphire Therapeutics Inc. | GEMP | Reno Seth Chief Commercial Officer |
14,286 | $7 | $100,002 | 18,286 (Direct) |
View |
| 2018-02-08 Purchase |
2018-02-12 4:31 pm |
Gemphire Therapeutics Inc. | GEMP | Gullans Steven R. Ph.D. Interim President & CEO Director |
71,429 | $7 | $500,003 | 930,252 (Indirect) |
View |
| 2017-03-10 Purchase |
2017-03-14 6:07 pm |
Gemphire Therapeutics Inc. | GEMP | SASSINE ANDY Director |
21,119 | $9.47 | $199,997 | 136,264 (Direct) |
View |
| 2017-03-10 Purchase |
2017-03-14 5:57 pm |
Gemphire Therapeutics Inc. | GEMP | LICHTINGER PEDRO Director |
10,559 | $9.47 | $99,994 | 59,833 (Direct) |
View |
| 2017-03-10 Purchase |
2017-03-14 5:46 pm |
Gemphire Therapeutics Inc. | GEMP | Hawryluk P. Kent Director |
25,000 | $9.47 | $236,750 | 81,889 (Direct Indirect) |
View |
| 2017-03-10 Purchase |
2017-03-14 5:33 pm |
Gemphire Therapeutics Inc. | GEMP | Gullans Steven R. Ph.D. Director |
52,798 | $9.47 | $499,997 | 858,823 (Indirect) |
View |
| 2016-08-10 Purchase |
2016-08-12 1:27 pm |
Gemphire Therapeutics Inc. | GEMP | Hawryluk P. Kent Director |
25,000 | $10 | $250,000 | 56,889 (Direct Indirect) |
View |
| 2016-08-10 Purchase |
2016-08-12 1:19 pm |
Gemphire Therapeutics Inc. | GEMP | LICHTINGER PEDRO Director |
10,000 | $10 | $100,000 | 49,274 (Direct) |
View |
| 2016-08-10 Purchase |
2016-08-12 1:15 pm |
Gemphire Therapeutics Inc. | GEMP | KOUSKY KENNETH W Director |
1,000 | $10 | $10,000 | 116,891 (Direct Indirect) |
View |
| 2016-08-10 Purchase |
2016-08-12 1:09 pm |
Gemphire Therapeutics Inc. | GEMP | Gullans Steven R. Ph.D. Director |
500,000 | $10 | $5,000,000 | 806,025 (Indirect) |
View |
| 2016-08-10 Purchase |
2016-08-12 1:06 pm |
Gemphire Therapeutics Inc. | GEMP | Reno Seth Chief Commercial Officer |
4,000 | $10 | $40,000 | 4,000 (Direct) |
View |
| 2016-08-10 Purchase |
2016-08-12 1:01 pm |
Gemphire Therapeutics Inc. | GEMP | Sooch Mina President & CEO Director |
52,500 | $10 | $525,000 | 693,732 (Direct Indirect) |
View |
| 2016-08-10 Purchase |
2016-08-12 12:54 pm |
Gemphire Therapeutics Inc. | GEMP | Lowenschuss David Chief Legal Off. & Secretary |
11,120 | $10 | $111,200 | 806,247 (Direct) |
View |
| 2016-08-10 Purchase |
2016-08-12 12:49 pm |
Gemphire Therapeutics Inc. | GEMP | MATHIESEN JEFFREY S Chief Financial Officer |
4,000 | $10 | $40,000 | 7,927 (Direct) |
View |
| 2016-08-10 Purchase |
2016-08-12 12:47 pm |
Gemphire Therapeutics Inc. | GEMP | Bisgaier Charles PhD Chair & Chief Scientific Off. Director 10% Owner |
51,750 | $10 | $517,500 | 1,244,440 (Direct Indirect) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported Date |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2018-05-01 Option Award |
2018-05-03 4:32 pm |
N/A 2028-04-30 |
Gemphire Therapeutics Inc. | GEMP | Gullans Steven R. Ph.D. President & CEO Director |
150,000 | $5.56 | 150,000 (Direct) |
View |
| 2018-01-29 Option Award |
2018-01-30 5:12 pm |
N/A 2028-01-28 |
Gemphire Therapeutics Inc. | GEMP | SASSINE ANDY Director |
10,800 | $10.44 | 10,800 (Direct) |
View |
| 2018-01-29 Option Award |
2018-01-30 5:04 pm |
N/A 2028-01-28 |
Gemphire Therapeutics Inc. | GEMP | LICHTINGER PEDRO Director |
10,800 | $10.44 | 10,800 (Direct) |
View |
| 2018-01-29 Option Award |
2018-01-30 4:52 pm |
N/A 2028-01-28 |
Gemphire Therapeutics Inc. | GEMP | KOUSKY KENNETH W Director |
10,800 | $10.44 | 10,800 (Direct) |
View |
| 2018-01-29 Option Award |
2018-01-30 4:44 pm |
N/A 2028-01-28 |
Gemphire Therapeutics Inc. | GEMP | Hawryluk P. Kent Director |
10,800 | $10.44 | 10,800 (Direct) |
View |
| 2018-01-28 Option Award |
2018-01-30 4:36 pm |
N/A 2028-01-27 |
Gemphire Therapeutics Inc. | GEMP | Bisgaier Charles PhD Chief Scien Officer & Chair Director 10% Owner |
48,000 | $10.1 | 48,000 (Direct) |
View |
| 2018-01-28 Option Award |
2018-01-30 4:27 pm |
N/A 2028-01-27 |
Gemphire Therapeutics Inc. | GEMP | Golden Lee Scott Chief Medical Officer |
148,000 | $10.1 | 148,000 (Direct) |
View |
| 2018-01-28 Option Award |
2018-01-30 4:20 pm |
N/A 2028-01-27 |
Gemphire Therapeutics Inc. | GEMP | MATHIESEN JEFFREY S Chief Financial Officer |
48,000 | $10.1 | 48,000 (Direct) |
View |
| 2018-01-28 Option Award |
2018-01-30 4:13 pm |
N/A 2028-01-27 |
Gemphire Therapeutics Inc. | GEMP | Reno Seth Chief Commercial Officer |
48,000 | $10.1 | 48,000 (Direct) |
View |
| 2018-01-29 Option Award |
2018-01-30 4:06 pm |
N/A 2028-01-28 |
Gemphire Therapeutics Inc. | GEMP | Gullans Steven R. Ph.D. Interim President & CEO Director |
60,000 | $10.44 | 60,000 (Direct) |
View |
| 2017-08-14 Exercise |
2017-08-16 4:10 pm |
N/A N/A |
Gemphire Therapeutics Inc. | GEMP | MATHIESEN JEFFREY S Chief Financial Officer |
3,207 | $3.59 | 14,134 (Direct) |
View |
| 2017-08-14 Exercise |
2017-08-16 4:10 pm |
2015-09-25 2025-09-24 |
Gemphire Therapeutics Inc. | GEMP | MATHIESEN JEFFREY S Chief Financial Officer |
3,207 | $3.59 | 14,134 (Direct) |
View |
| 2017-08-10 Exercise |
2017-08-15 4:22 pm |
N/A N/A |
Gemphire Therapeutics Inc. | GEMP | MATHIESEN JEFFREY S Chief Financial Officer |
3,000 | $3.59 | 45,093 (Direct) |
View |
| 2017-08-10 Exercise |
2017-08-15 4:22 pm |
2015-09-25 2025-09-24 |
Gemphire Therapeutics Inc. | GEMP | MATHIESEN JEFFREY S Chief Financial Officer |
3,000 | $3.59 | 45,093 (Direct) |
View |
| 2017-08-10 Exercise |
2017-08-11 4:07 pm |
N/A N/A |
Gemphire Therapeutics Inc. | GEMP | MATHIESEN JEFFREY S Chief Financial Officer |
3,000 | $3.59 | 10,927 (Direct) |
View |
| 2017-08-10 Exercise |
2017-08-11 4:07 pm |
2015-09-25 2025-09-24 |
Gemphire Therapeutics Inc. | GEMP | MATHIESEN JEFFREY S Chief Financial Officer |
3,000 | $3.59 | 10,927 (Direct) |
View |
| 2017-07-31 Exercise |
2017-08-02 4:11 pm |
N/A N/A |
Gemphire Therapeutics Inc. | GEMP | Bisgaier Charles PhD Chief Scientific Off. & Chair Director 10% Owner |
4,474 | $1.344 | 1,248,914 (Direct) |
View |
| 2017-07-31 Exercise |
2017-08-02 4:11 pm |
2015-06-29 2025-06-28 |
Gemphire Therapeutics Inc. | GEMP | Bisgaier Charles PhD Chief Scientific Off. & Chair Director 10% Owner |
4,474 | $1.344 | 1,248,914 (Direct) |
View |
| 2017-05-30 Option Award |
2017-05-31 4:25 pm |
N/A 2027-05-29 |
Gemphire Therapeutics Inc. | GEMP | Gullans Steven R. Ph.D. Interim President & CEO Director |
60,000 | $10.26 | 60,000 (Direct) |
View |
| 2017-03-28 Option Award |
2017-03-29 4:17 pm |
N/A 2027-03-27 |
Gemphire Therapeutics Inc. | GEMP | Golden Lee Scott Chief Medical Officer |
20,000 | $11.15 | 20,000 (Direct) |
View |
| 2017-03-10 Purchase |
2017-03-14 6:07 pm |
2017-03-10 2022-03-15 |
Gemphire Therapeutics Inc. | GEMP | SASSINE ANDY Director |
15,840 | $9.47 | 136,264 (Direct) |
View |
| 2017-03-10 Purchase |
2017-03-14 5:57 pm |
2017-03-10 2022-03-15 |
Gemphire Therapeutics Inc. | GEMP | LICHTINGER PEDRO Director |
7,920 | $9.47 | 59,833 (Direct) |
View |
| 2017-03-10 Purchase |
2017-03-14 5:46 pm |
2017-03-10 2022-03-15 |
Gemphire Therapeutics Inc. | GEMP | Hawryluk P. Kent Director |
18,750 | $9.47 | 81,889 (Indirect) |
View |
| 2017-03-10 Purchase |
2017-03-14 5:33 pm |
2017-03-10 2022-03-15 |
Gemphire Therapeutics Inc. | GEMP | Gullans Steven R. Ph.D. Director |
39,599 | $9.47 | 858,823 (Indirect) |
View |
| 2017-02-01 Other |
2017-02-03 4:25 pm |
N/A N/A |
Gemphire Therapeutics Inc. | GEMP | KOUSKY KENNETH W Director |
101,406 | $0 | 6,463 (Indirect) |
View |
| 2017-02-01 Other |
2017-02-03 4:25 pm |
N/A N/A |
Gemphire Therapeutics Inc. | GEMP | KOUSKY KENNETH W Director |
110,428 | $0 | 6,463 (Indirect) |
View |
| 2016-11-25 Option Award |
2016-11-29 4:29 pm |
N/A 2026-08-03 |
Gemphire Therapeutics Inc. | GEMP | Sooch Mina President & CEO Director |
120,000 | $10 | 600,000 (Direct) |
View |
| 2016-10-05 Option Award |
2016-10-06 4:25 pm |
N/A 2026-10-04 |
Gemphire Therapeutics Inc. | GEMP | Golden Lee Scott Chief Medical Officer |
126,000 | $10.8 | 126,000 (Direct) |
View |
| 2016-09-30 Option Award |
2016-10-03 4:32 pm |
N/A 2026-08-03 |
Gemphire Therapeutics Inc. | GEMP | Sooch Mina President & CEO Director |
120,000 | $10 | 480,000 (Direct) |
View |
| 2016-08-10 Conversion |
2016-08-12 1:27 pm |
N/A N/A |
Gemphire Therapeutics Inc. | GEMP | Hawryluk P. Kent Director |
7,457 | $0 | 56,889 (Indirect) |
View |
| 2016-08-10 Other |
2016-08-12 1:27 pm |
N/A N/A |
Gemphire Therapeutics Inc. | GEMP | Hawryluk P. Kent Director |
816 | $6.706 | 56,889 (Indirect) |
View |
| 2016-08-10 Conversion |
2016-08-12 1:27 pm |
N/A N/A |
Gemphire Therapeutics Inc. | GEMP | Hawryluk P. Kent Director |
23,616 | $6.706 | 56,889 (Indirect) |
View |
| 2016-08-10 Conversion |
2016-08-12 1:27 pm |
N/A N/A |
Gemphire Therapeutics Inc. | GEMP | Hawryluk P. Kent Director |
7,457 | $0 | 56,889 (Indirect) |
View |
| 2016-08-10 Conversion |
2016-08-12 1:27 pm |
N/A N/A |
Gemphire Therapeutics Inc. | GEMP | Hawryluk P. Kent Director |
150,000 | $6.706 | 56,889 (Indirect) |
View |
| 2016-08-10 Conversion |
2016-08-12 1:24 pm |
N/A N/A |
Gemphire Therapeutics Inc. | GEMP | SASSINE ANDY Director |
75,080 | $0 | 115,145 (Direct) |
View |
| 2016-08-10 Other |
2016-08-12 1:24 pm |
N/A N/A |
Gemphire Therapeutics Inc. | GEMP | SASSINE ANDY Director |
8,212 | $6.706 | 115,145 (Direct) |
View |
| 2016-08-10 Conversion |
2016-08-12 1:24 pm |
N/A N/A |
Gemphire Therapeutics Inc. | GEMP | SASSINE ANDY Director |
31,853 | $6.706 | 115,145 (Direct) |
View |
| 2016-08-10 Conversion |
2016-08-12 1:24 pm |
N/A N/A |
Gemphire Therapeutics Inc. | GEMP | SASSINE ANDY Director |
75,080 | $0 | 115,145 (Direct) |
View |
| 2016-08-10 Conversion |
2016-08-12 1:24 pm |
N/A N/A |
Gemphire Therapeutics Inc. | GEMP | SASSINE ANDY Director |
200,000 | $6.706 | 115,145 (Direct) |
View |
| 2016-08-10 Conversion |
2016-08-12 1:19 pm |
N/A N/A |
Gemphire Therapeutics Inc. | GEMP | LICHTINGER PEDRO Director |
39,274 | $6.706 | 49,274 (Direct) |
View |
| 2016-08-10 Conversion |
2016-08-12 1:19 pm |
N/A N/A |
Gemphire Therapeutics Inc. | GEMP | LICHTINGER PEDRO Director |
250,000 | $6.706 | 49,274 (Direct) |
View |
| 2016-08-10 Conversion |
2016-08-12 1:15 pm |
N/A N/A |
Gemphire Therapeutics Inc. | GEMP | KOUSKY KENNETH W Director |
95,439 | $0 | 116,891 (Indirect) |
View |
| 2016-08-10 Other |
2016-08-12 1:15 pm |
N/A N/A |
Gemphire Therapeutics Inc. | GEMP | KOUSKY KENNETH W Director |
10,439 | $6.706 | 116,891 (Indirect) |
View |
| 2016-08-10 Conversion |
2016-08-12 1:15 pm |
N/A N/A |
Gemphire Therapeutics Inc. | GEMP | KOUSKY KENNETH W Director |
116,891 | $6.706 | 116,891 (Indirect) |
View |
| 2016-08-10 Conversion |
2016-08-12 1:15 pm |
N/A N/A |
Gemphire Therapeutics Inc. | GEMP | KOUSKY KENNETH W Director |
95,439 | $0 | 116,891 (Indirect) |
View |
| 2016-08-10 Conversion |
2016-08-12 1:15 pm |
N/A N/A |
Gemphire Therapeutics Inc. | GEMP | KOUSKY KENNETH W Director |
746,500 | $6.706 | 116,891 (Indirect) |
View |
| 2016-08-10 Conversion |
2016-08-12 1:09 pm |
N/A N/A |
Gemphire Therapeutics Inc. | GEMP | Gullans Steven R. Ph.D. Director |
306,025 | $6.706 | 806,025 (Indirect) |
View |
| 2016-08-10 Conversion |
2016-08-12 1:09 pm |
N/A N/A |
Gemphire Therapeutics Inc. | GEMP | Gullans Steven R. Ph.D. Director |
2,000,000 | $6.706 | 806,025 (Indirect) |
View |
| 2016-08-10 Conversion |
2016-08-12 1:01 pm |
N/A N/A |
Gemphire Therapeutics Inc. | GEMP | Sooch Mina President & CEO Director |
11,078 | $0 | 693,732 (Indirect) |
View |
| 2016-08-10 Other |
2016-08-12 1:01 pm |
N/A N/A |
Gemphire Therapeutics Inc. | GEMP | Sooch Mina President & CEO Director |
1,212 | $6.706 | 693,732 (Indirect) |
View |
| 2016-08-10 Conversion |
2016-08-12 1:01 pm |
N/A N/A |
Gemphire Therapeutics Inc. | GEMP | Sooch Mina President & CEO Director |
27,141 | $6.706 | 693,732 (Indirect) |
View |
| 2016-08-10 Conversion |
2016-08-12 1:01 pm |
N/A N/A |
Gemphire Therapeutics Inc. | GEMP | Sooch Mina President & CEO Director |
11,078 | $0 | 693,732 (Indirect) |
View |
| 2016-08-10 Conversion |
2016-08-12 1:01 pm |
N/A N/A |
Gemphire Therapeutics Inc. | GEMP | Sooch Mina President & CEO Director |
175,000 | $6.706 | 693,732 (Indirect) |
View |
| 2016-08-10 Conversion |
2016-08-12 12:56 pm |
N/A N/A |
Gemphire Therapeutics Inc. | GEMP | Oniciu Carmen Daniela Vice President |
2,237 | $0 | 152,401 (Direct) |
View |
| 2016-08-10 Other |
2016-08-12 12:56 pm |
N/A N/A |
Gemphire Therapeutics Inc. | GEMP | Oniciu Carmen Daniela Vice President |
245 | $6.706 | 152,401 (Direct) |
View |
| 2016-08-10 Conversion |
2016-08-12 12:56 pm |
N/A N/A |
Gemphire Therapeutics Inc. | GEMP | Oniciu Carmen Daniela Vice President |
2,237 | $0 | 152,401 (Direct) |
View |
| 2016-08-10 Conversion |
2016-08-12 12:49 pm |
N/A N/A |
Gemphire Therapeutics Inc. | GEMP | MATHIESEN JEFFREY S Chief Financial Officer |
3,927 | $6.706 | 7,927 (Direct) |
View |
| 2016-08-10 Conversion |
2016-08-12 12:49 pm |
N/A N/A |
Gemphire Therapeutics Inc. | GEMP | MATHIESEN JEFFREY S Chief Financial Officer |
25,000 | $6.706 | 7,927 (Direct) |
View |
| 2016-08-10 Conversion |
2016-08-12 12:47 pm |
N/A N/A |
Gemphire Therapeutics Inc. | GEMP | Bisgaier Charles PhD Chair & Chief Scientific Off. Director 10% Owner |
59,561 | $0 | 1,244,440 (Indirect) |
View |
| 2016-08-10 Other |
2016-08-12 12:47 pm |
N/A N/A |
Gemphire Therapeutics Inc. | GEMP | Bisgaier Charles PhD Chair & Chief Scientific Off. Director 10% Owner |
6,515 | $6.706 | 1,244,440 (Indirect) |
View |
| 2016-08-10 Conversion |
2016-08-12 12:47 pm |
N/A N/A |
Gemphire Therapeutics Inc. | GEMP | Bisgaier Charles PhD Chair & Chief Scientific Off. Director 10% Owner |
16,144 | $6.706 | 1,244,440 (Indirect) |
View |
| 2016-08-10 Conversion |
2016-08-12 12:47 pm |
N/A N/A |
Gemphire Therapeutics Inc. | GEMP | Bisgaier Charles PhD Chair & Chief Scientific Off. Director 10% Owner |
19,228 | $6.706 | 1,244,440 (Indirect) |
View |
| 2016-08-10 Conversion |
2016-08-12 12:47 pm |
N/A N/A |
Gemphire Therapeutics Inc. | GEMP | Bisgaier Charles PhD Chair & Chief Scientific Off. Director 10% Owner |
59,561 | $0 | 1,244,440 (Indirect) |
View |
| 2016-08-10 Conversion |
2016-08-12 12:47 pm |
N/A N/A |
Gemphire Therapeutics Inc. | GEMP | Bisgaier Charles PhD Chair & Chief Scientific Off. Director 10% Owner |
100,000 | $6.706 | 1,244,440 (Indirect) |
View |
| 2016-08-10 Conversion |
2016-08-12 12:47 pm |
N/A N/A |
Gemphire Therapeutics Inc. | GEMP | Bisgaier Charles PhD Chair & Chief Scientific Off. Director 10% Owner |
125,000 | $6.706 | 1,244,440 (Indirect) |
View |
| 2016-08-04 Option Award |
2016-08-08 5:37 pm |
N/A 2026-08-03 |
Gemphire Therapeutics Inc. | GEMP | SASSINE ANDY Director |
60,000 | $10 | 60,000 (Direct) |
View |
| 2016-08-04 Option Award |
2016-08-08 5:31 pm |
N/A 2026-08-03 |
Gemphire Therapeutics Inc. | GEMP | LICHTINGER PEDRO Director |
60,000 | $10 | 60,000 (Direct) |
View |
| 2016-08-04 Option Award |
2016-08-08 5:23 pm |
N/A 2026-08-03 |
Gemphire Therapeutics Inc. | GEMP | KOUSKY KENNETH W Director |
60,000 | $10 | 60,000 (Direct) |
View |
|
© 2005-2018 SecForm4.Com All rights reserved. Archives: 2018 2017 2016 2015 2014 2013 ... Thu, 24 May 2018 11:00:10 -0500 |
SEC is the U.S. Securities and Exchange Commission. EDGAR is a trademark of the SEC. SecForm4.Com is not affiliated with or approved by the U.S. Securities and Exchange Commission (SEC). Terms of Use | Privacy Statement | |